Re­vi­sion Pro­cess

Pub­lic com­ment is par­tic­u­lar­ly im­por­tant in the de­vel­op­ment of clin­i­cal prac­tice rec­om­men­da­tions; it pro­motes trans­paren­cy and pro­vides key stake hold­ers the op­por­tu­ni­ty to iden­ti­fy and ad­dress gaps in care. The ADA holds a year-​long pub­lic com­ment pe­ri­od re­quest­ing feed­back on the Stan­dards of Care. The PPC re­views com­piled feed­back from the pub­lic in prepa­ra­tion for the an­nu­al up­date but con­sid­ers more press­ing up­dates through­out the year, which may be pub­lished as “liv­ing” Stan­dards up­dates. Feed­back from the larg­er clin­i­cal com­mu­ni­ty and gen­er­al pub­lic was in­valu­able for the re­vi­sion of the Stan­dards of Care—2022. Read­ers who wish to com­ment on the 2023 Stan­dards of Care are in­vit­ed to do so at pro­fes­sion­al.di­a­betes.org/​SOC.

Feed­back for the Stan­dards of Care is also ob­tained from ex­ter­nal peer re­view­ers. The Stan­dards of Care is re­viewed by ADA clin­i­cal lead­er­ship and sci­en­tific and med­i­cal staff and is ap­proved by the ADA Board of Di­rec­tors, which in­cludes health care pro­fes­sion­als, sci­en­tists, and lay peo­ple. The ACC per­forms an in­de­pen­dent ex­ter­nal peer re­view and the ACC Board of Di­rec­tors pro­vides en­dorse­ment of Sec­tion 10, “Car­dio­vas­cu­lar and Metabol­ic Risk.” The ADA ad­heres to the Coun­cil for Med­i­cal Spe­cial­ty So­ci­eties “Re­vised CMSS Prin­ci­ples for Clin­i­cal Prac­tice Guide­line De­vel­op­men­t” (4).